Proteomics is going mainstream.  Where genomics couldn’t find all the answers proteomics is stepping up to the plate.

Who will be the Illumina of Proteomics?  Will these new biomarkers redefine disease definitions? 
Will Proteomic Assays displace current Genomic Assays? 

Find out all about it and more in this comprehensive report.
Proteomic Biomarker Analytics is just finding its feet, but the opportunity is to understand the front line players, the actual proteins and protein complexes, that do the work of managing cellular life. Players are reporting double digit growth. Venture capital is well involved.  Learn about this market including the issues and outlooks.  This technology could possibly displace most cancer diagnostic protocols AND save money at the same time.  The report forecasts the market size out for five years for a number of different market segments.  

Our research makes you the expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report.  Your credit card order sends the report to your inbox instantly.  Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges.
All report data is available in Excel format on request.
Make investment decisions and valuations with confidence using the latest data.